Sign up to save your podcasts
Or
Share Why Biopharma Investment Requires a Different Mindset
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Why Biopharma Investment Requires a Different Mindset
In the latest episode of Pathfinders, Noël Brown, Head of US Biotechnology Investment Banking at RBC Capital Markets, reveals why he’s feeling optimistic about M&A in biopharma and how leading in biotech investment and corporates needs visionary long-term thinking.
View all episodes
By RBC Capital Markets
5
1212 ratings
In the latest episode of Pathfinders, Noël Brown, Head of US Biotechnology Investment Banking at RBC Capital Markets, reveals why he’s feeling optimistic about M&A in biopharma and how leading in biotech investment and corporates needs visionary long-term thinking.
More shows like Pathfinders in Biopharma
View all
Motley Fool Hidden Gems Investing
3,217 Listeners
WSJ Your Money Briefing
1,720 Listeners
Exchanges
970 Listeners
Odd Lots
1,967 Listeners
WSJ Tech News Briefing
1,657 Listeners
The a16z Show
1,093 Listeners
The Long Run with Luke Timmerman
124 Listeners
The Readout Loud
337 Listeners
Wall Street Breakfast
1,038 Listeners
Thoughts on the Market
1,302 Listeners
The Journal.
6,089 Listeners
BioCentury This Week
34 Listeners
RBC's Markets in Motion
43 Listeners
Biotech Hangout
23 Listeners
Industries in Motion
10 Listeners
Powering Sustainable Ideas
0 Listeners
The Markets
80 Listeners
Strategic Alternatives
19 Listeners
The Top Line
15 Listeners
Macro Minutes
3 Listeners